Novel functions for 2-phenylbenzimidazole-5-sulphonic acid: Inhibition of ovarian cancer cell responses and tumour angiogenesisopen access
- Authors
- Kim, Min Su; Kim, Jae Hyeon; Ahn, Eun-Kyung; Cho, Young-Rak; Han, Surim; Lee, Choong-Hyun; Bae, Gyu-Un; Oh, Joa Sub; Kim, Kyu-Bong; Seo, Dong-Wan
- Issue Date
- Feb-2020
- Publisher
- WILEY
- Keywords
- 2-phenylbenzimidazole-5-sulphonic acid; angiogenesis; ovarian cancer; p38(MAPK)
- Citation
- JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, v.24, no.4, pp 2688 - 2700
- Pages
- 13
- Journal Title
- JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Volume
- 24
- Number
- 4
- Start Page
- 2688
- End Page
- 2700
- URI
- https://scholarworks.sookmyung.ac.kr/handle/2020.sw.sookmyung/2513
- DOI
- 10.1111/jcmm.14989
- ISSN
- 1582-1838
1582-4934
- Abstract
- In this study, we investigated the effects and molecular mechanisms of 2-phenylbenzimidazole-5-sulphonic acid (PBSA), an ultraviolet B protecting agent used in sunscreen lotions and moisturizers, on ovarian cancer cell responses and tumour angiogenesis. PBSA treatment markedly blocked mitogen-induced invasion through down-regulation of matrix metalloproteinase (MMP) expression and activity in ovarian cancer SKOV-3 cells. In addition, PBSA inhibited mitogen-induced cell proliferation by suppression of cyclin-dependent kinases (Cdks), but not cyclins, leading to pRb hypophosphorylation and G(1) phase cell cycle arrest. These anti-cancer activities of PBSA in ovarian cancer cell invasion and proliferation were mediated by the inhibition of mitogen-activated protein kinase kinase 3/6-p38 mitogen-activated protein kinase (MKK3/6-p38(MAPK)) activity and subsequent down-regulation of MMP-2, MMP-9, Cdk4, Cdk2 and integrin beta 1, as evidenced by treatment with p38(MAPK) inhibitor SB203580. Furthermore, PBSA suppressed the expression and secretion of vascular endothelial growth factor in SKOV-3 cells, leading to inhibition of capillary-like tubular structures in vitro and angiogenic sprouting ex vivo. Taken together, our results demonstrate the pharmacological effects and molecular targets of PBSA on modulating ovarian cancer cell responses and tumour angiogenesis, and suggest further evaluation and development of PBSA as a promising chemotherapeutic agent for the treatment of ovarian cancer.
- Files in This Item
-
Go to Link
- Appears in
Collections - 약학대학 > 약학부 > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.